Improved resuscitation after cardiac arrest in rats expressing the baculovirus caspase inhibitor protein p35 in central neurons

Anesthesiology

Volumn 99, Issue 1, 2003, Pages 112-121

  Vogel, Peter ^f   Putten, Herman V D ^a   Popp, Erik ^f   Krumnikl, Jakub J ^f   Teschendorf, Peter ^f   Galmbacher, Roland ^f   Kisielow, Malgorzata ^c   Wiessner, Christoph ^a   Schmitz, Albert ^a   Tomaselli, Kevin J ^b   Schmitz, Bernd ^d   Martin, Eike ^f   Böttiger, Bernd W ^e  

^a NOVARTIS PHARMA AG   (Switzerland)

^b PFIZER INC   (United States)

^c Institute for Research in Biomed   (Switzerland)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE INHIBITOR; PROTEIN P35;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; HEART ARREST; HIPPOCAMPUS; HISTOPATHOLOGY; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESUSCITATION; TRANSGENE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BACULOVIRIDAE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; BRAIN CHEMISTRY; BRAIN ISCHEMIA; CARDIOPULMONARY RESUSCITATION; CASPASES; CELL DEATH; ELECTROSHOCK; ENZYME INHIBITORS; HEART ARREST; HIPPOCAMPUS; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; INHIBITOR OF APOPTOSIS PROTEINS; MICROINJECTIONS; NERVOUS SYSTEM DISEASES; NEURONS; RATS; RATS, WISTAR; SURVIVAL; VIRAL PROTEINS;

EID: 0013095760     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200307000-00020     Document Type: Article

References (53)

1. Brain Resuscitation Clinical Trial II Study Group: A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. N Engl J Med 1991; 324:1225-31
2. Brain Resuscitation Clinical Trial I Study Group: Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 1986; 314:397-403
3. The Hypothermia after Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346:549-56
4. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346:557-63
5. Padosch SA, Kern KB, Böttiger BW: Therapeutic hypothermia after cardiac arrest. N Engl J Med 2002; 347:63-5
6. Böttiger BW, Bode C, Kern S, Gries A, Gust R, Glatzer R, Bauer H, Motsch J, Martin E: Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: A prospective clinical trial. Lancet 2001; 357:1583-5
7. Böttiger BW, Padosch SA, Wenzel V: Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002; 347:1281-2
8. Hossmann K-A: Disturbances of cerebral protein synthesis and ischemic cell death. Prog Brain Res 1993; 96:161-77
9. Safar P: Cerebral resuscitation after cardiac arrest: A review. Circulation 1986; 74(suppl IV):IV138-53
10. Böttiger BW, Schmitz B, Wiessner C, Vogel P, Hossmann KA: Neuronal stress response and neuronal cell damage after cardiocirculatory arrest in rats. J Cereb Blood Flow Metab 1998; 18:1077-87
11. Choi DW: Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 1996; 6:667-72
12. Thornberry NA: Caspases: Key mediators of apoptosis. Chem Biol 1998; 5:R97-103
13. Villa P, Kaufmann SH, Earnshaw WC: Caspases and caspase inhibitors. Trends Biochem Sci 1997; 22:388-93
14. Cohen GM: Caspases: The executioners of apoptosis. Biochem J 1997; 326:1-16
15. Gillardon F, Böttiger BW, Schmitz B, Zimmermann M, Hossmann K-A: Activation of CPP-32 protease in hippocampal neurons following ischemia and epilepsy. Mol Brain Res 1997; 50:16-22
16. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu-Sasamata M, Yuan J, Moskowitz MA: Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci U S A 1997; 94:2007-12
17. Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gomez-Isla T, Hyman BT, Moskowitz MA: Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab 1998; 18:238-47
18. Wiessner C, Sauer D, Alaimo D, Allegrini PR: Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo. Cell Mol Biol (Noisy-le-grand) 2000; 46:53-62
19. Friedlander RM, Gagliardini V, Hara H, Fink KB, Li W, MacDonald G, Fishman MC, Greenberg AH, Moskowitz MA, Yuan J: Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med 1997; 185:933-40
20. Schielke GP, Yang GY, Shivers BD, Betz AL: Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 1998; 18:180-5
21. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J: Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92:501-9
22. Shibata M, Hisahara S, Hara H, Yamawaki T, Fukuuchi Y, Yuan J, Okano H, Miura M: Caspases determine the vulnerability of oligodendrocytes in the ischemic brain. J Clin Invest 2000; 106:643-53
23. Holtzman DM, Deshmukh M: Caspases: A treatment target for neurodegenerative disease? Nat Med 1997; 3:954-5
24. Zhou Q, Krebs JF, Snipas SJ, Price A, Alnemri ES, Tomaselli KJ, Salvesen GS: Interaction of the baculovirus anti-apoptotic protein p35 with caspases: Specificity, kinetics, and characterization of the caspase/p35 complex. Biochemistry 1998; 37:10757-65
25. Pettmann B, Henderson CE: Neuronal cell death. Neuron 1998; 20:633-47
26. Xue D, Horvitz HR: Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 1995; 377:248-51
27. Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P, Ferenz C, Franklin S, Ghayur T, Li P, Licari P, Mankovich J, Shi L, Greenber AH, Miller LK, Wong WW: Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 1995; 269:1885-8
28. Robertson NM, Zangrilli J, Fernandes-Alnemri T, Friesen PD, Litwack G, Alnemri ES: Baculovirus P35 inhibits the glucocorticoid-mediated pathway of cell death. Cancer Res 1997; 57:43-7
29. White K, Tahaoglu E, Steller H: Cell killing by the Drosophila gene reaper. Science 1996; 271:805-7
30. Bose R, Chen P, Loconti A, Grullich C, Abrams JM, Kolesnick RN: Ceramide generation by the Reaper protein is not blocked by the caspase inhibitor, p35. J Biol Chem 1998; 273:28852-9
31. Martinou I, Fernandez PA, Missotten M, White E, Allet B, Sadoul R, Martinou JC: Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J Cell Biol 1995; 128:201-8
32. Texido G, Eibel H, Le Gros G, van der Putten H: Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses. J Immunol 1994; 153:3028-42
33. Moll J, Schmidt A, van der Putten H, Plug R, Ponta H, Herrlich P, Zoller M: Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T cells. J Immunol 1996; 156:2085-94
34. Wiessner C, Allegrini PR, Rupalla K, Sauer D, Oltersdorf T, McGregor AL, Bischoff S, Böttiger BW, van der Putten H: Neuron-specific transgene expression of Bcl-XL but not Bcl-2 genes reduced lesion size after permanent middle cerebral artery occlusion in mice. Neurosci Lett 1999; 268:119-22
35. Böttiger BW, Krumnikl JJ, Gass P, Schmitz B, Motsch J, Martin E: The cerebral "no-reflow" phenomenon after cardiac arrest in rats: Influence of low-flow reperfusion. Resuscitation 1997; 34:79-87
36. Katz L, Ebmeyer U, Safar P, Radovsky A, Neumar R: Outcome model of asphyxial cardiac arrest in rats. J Cereb Blood Flow Metab 1995; 15:1032-9
37. Neumar RW, Bircher NG, Sim KM, Xiao F, Zadach KS, Radovsky A, Katz L, Ebmeyer E, Safar P: Epinephrine and sodium bicarbonate during CPR following asphyxial cardiac arrest in rats. Resuscitation 1995; 29:249-63
38. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501
39. Wiessner C, Brink I, Lorenz P, Neumann-Haefelin T, Vogel P, Yamashita K: Cyclin D1 messenger RNA is induced in microglia rather than neurons following transient forebrain ischemia. Neuroscience 1996; 72:947-58
40. Luthi A, Putten H, Botteri FM, Mansuy IM, Meins M, Frey U, Sansig G, Portet C, Schmutz M, Schroder M, Nitsch C, Laurent JP, Monard D: Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation. J Neurosci 1997; 17:4688-99
41. Appleby DW, Modak SP: DNA degradation in terminally differentiating lens fiber cells from chick embryos. Proc Natl Acad Sci U S A 1977; 74:5579-83
42. Charriaut-Marlangue C, Margaill I, Represa A, Popovici T, Plotkine M, Ben-Ari Y: Apoptosis and necrosis after reversible focal ischemia: An in situ DNA fragmentation analysis. J Cereb Blood Flow Metab 1996; 16:186-94
43. Chopp M, Li Y, Jiang N, Zhang RL, Prostak J: Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 1996; 16:578-84
44. Li Y, Chopp M, Jiang N, Yao F, Zaloga C: Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1995; 15:389-97
45. Heron A, Pollard H, Dessi F, Moreau J, Lasbennes F, Ben Ari Y, Charriaut Marlangue C: Regional variability in DNA fragmentation after global ischemia evidenced by combined histological and gel electrophoresis observations in the rat brain. J Neurochem 1993; 61:1973-6
46. Viswanath V, Wu Z, Fonck C, Wei Q, Boonplueang R, Andersen JK: Transgenic mice neuronally expressing baculoviral p35 are resistant to diverse types of induced apoptosis, including seizure-associated neurodegeneration. Proc Natl Acad Sci U S A 2000; 97:2270-5
47. Ekert PG, Silke J, Vaux DL: Caspase inhibitors. Cell Death Differ 1999; 6:1081-6
48. Borner C, Monney L: Apoptosis without caspases: An inefficient molecular guillotine? Cell Death Differ 1999; 6:497-507
49. Johnson DE: Noncaspase proteases in apoptosis. Leukemia 2000; 14:1695-703
50. Leist M, Jaattela M: Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2:589-98
51. Mathiasen IS, Jaattela M: Triggering caspase-independent cell death to combat cancer. Trends Mol Med 2002; 8:212-20
52. Yamashima T: Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 2000; 62:273-95
53. Böttiger BW, Motsch J, Braun V, Martin E, Kirschfink M: Marked activation of complement and leukocytes and an increase in the concentrations of soluble endothelial adhesion molecules during cardiopulmonary resuscitation and early reperfusion after cardiac arrest in humans. Crit Care Med 2002; 30:2473-80